title: [Do antibodies provide advantages for the therapy of Alzheimer's disease? Solanezumab: the jury is still out].
authors.forename: Oliver
authors.initials: O
authors.lastname: Peters
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D016229:Amyloid beta-Peptides; D061067:Antibodies, Monoclonal, Humanized